Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus fentanyl mechanistic study in treatment-resistant anxiety
ACTRN12617001177347Phase 2Not yet recruiting
- Sponsor
- University of Otago
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ketamine in generalized anxiety disorder (GAD) and Social Anxiety Disorder (SAD) (2 arms), sponsored by University of Otago. Primary endpoint: Magnetic Resonance Imaging scans. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on ACTRN12617001177347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001177347.